Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management and prognosis of skewer foreign body ingestion in dogs: A comparative study of 114 cases following emesis, endoscopic retrieval or surgical removal.

Australian veterinary journal·2025

Same author

Canine meningitis and meningoencephalitis in eastern Australia.

Australian veterinary journal·2025

Same author

Influence of routine follow-up radiographs on recommendations for management of antebrachial fractures in dogs.

Australian veterinary journal·2025

Same author

The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus.

The Journal of small animal practice·2025

Same author

Effects of age on accuracy of advanced imaging modalities in identifying intervertebral disc extrusions in Dachshunds.

Australian veterinary journal·2024

Same author

Efficacy of dupilumab in real-life settings: a STROBE study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2024

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Genetically determined neuropathy (CMT 1A) accompanied by immune dysfunction: a case report.

Zsuzsanna Pál¹, E Kiss, A Gál

¹Department of Neurology, University of Debrecen, Debrecen, Hungary. zsuzsanna.pal@gmail.com

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]

|March 11, 2009

Summary

Charcot-Marie-Tooth type 1A (CMT1A), a neuropathy caused by PMP22 gene duplication, may involve immune system dysfunction. This study found reduced immunoglobulin G levels and vasculitis in affected siblings, suggesting immune involvement in some CMT1A cases.

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Area of Science:

Neuroscience
Genetics
Immunology

Background:

Peripheral Myelin Protein 22 (PMP22) is crucial for myelin compaction in Schwann cells.
Charcot-Marie-Tooth type 1A (CMT1A) is a hereditary demyelinating neuropathy linked to PMP22 gene duplication.
Existing literature suggests potential, but limited, evidence for immune system involvement in CMT1A pathophysiology.

Observation:

This study investigated three siblings with the PMP22 gene duplication characteristic of CMT1A.
All three siblings presented with significantly reduced serum immunoglobulin G (IgG) levels.
The two female siblings also exhibited sural nerve vasculitis.

Findings:

The observed reduction in serum IgG levels in all affected siblings indicates a potential B-cell dysfunction.
The presence of sural nerve vasculitis in two siblings suggests an autoimmune or inflammatory component.
These findings collectively support the hypothesis that immune dysregulation can be a feature of CMT1A.

Implications:

Immune dysfunction may play a significant role in the pathophysiology of CMT1A in a subset of patients.
Further research into immune mechanisms could reveal novel therapeutic targets for CMT1A.
This study highlights the importance of considering immune system evaluation in the clinical management of CMT1A.